Armistice Capital, LLC Amryt Pharma PLC Transaction History

Armistice Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$6.68 - $7.58 $1.96 Million - $2.23 Million	-294,000 Reduced 23.11%	978,000 $7.14 Million
Q3 2022 Nov 14, 2022	BUY	$6.8 - $8.01 $639,200 - $752,940	94,000 Added 7.98%	1,272,000 $8.8 Million
Q2 2022 Aug 15, 2022	BUY	$6.85 - $8.87 $1.22 Million - $1.58 Million	178,000 Added 17.8%	1,178,000 $8.23 Million
Q1 2022 May 16, 2022	BUY	$6.3 - $10.86 $1.26 Million - $2.17 Million	200,000 Added 25.0%	1,000,000 $8.27 Million
Q4 2021 Feb 14, 2022	BUY	$9.44 - $12.24 $1.66 Million - $2.15 Million	176,000 Added 28.21%	800,000 $8.64 Million
Q3 2021 Nov 15, 2021	BUY	$9.63 - $12.47 $2.77 Million - $3.59 Million	288,000 Added 85.71%	624,000 $7.52 Million
Q2 2021 Aug 16, 2021	BUY	$10.9 - $14.29 $1.48 Million - $1.94 Million	136,000 Added 68.0%	336,000 $4.08 Million
Q4 2020 Feb 16, 2021	SELL	$12.22 - $14.16 $1.3 Million - $1.5 Million	-106,000 Reduced 34.64%	200,000 $2.83 Million
Q3 2020 Nov 16, 2020	BUY	$10.8 - $13.5 $3.3 Million - $4.13 Million	306,000 New	306,000 $3.78 Million

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.